24 Apr 2020
Day (& Year!) of Immunology events, public lectures and more
![]() |
| Professor Nicola Harris is one of the speakers at the 2020 Day of Immunology public lecture on 15 May. RSVP here |
Monash University's Department of Immunology and Pathology is a major contributor to the event. Professor Nicola Harris, a research group leader in the department, will be one of the three speakers for the 15 May public lecture. RSVP here
Prof Harris will be speaking on worms! Not earthworms, but parasite worms such as tapeworms and hookworms, known collectively as helminths, which are transmitted by soil. When they get into us, they live in our gastrointestinal tract. We have a long evolutionary history of co-existence with these parasites, and our immune system has developed a variety of responses to these soil transmitted helminths (STH), and their interactions with our immune system and the intestinal microbiome.
Dr Runa Lindblom, LEGO Master!
![]() |
Dr Runa Lindblom (left) with a team mate, working on the LEGO
challenge. Image: Channel 9
|
See the Channel 9 story: 9now.nine.com.au/lego-masters/lego-masters-2020-runa-brain-tumour/0c306475-3a64-4513-b83f-51e6f9c13b18
9 Apr 2020
Professor Terry O'Brien appointed Head of Central Clinical School
Congratulations to Professor Terry O'Brien on his appointment as Head of Central Clinical School! Professor Christina Mitchell AO, Dean of Monash Medicine, Nursing and Health Sciences writes:
"It is my great pleasure to formally announce the appointment of Professor Terence (Terry) O’Brien as Head of School, Central Clinical School, following an international search.
"It is my great pleasure to formally announce the appointment of Professor Terence (Terry) O’Brien as Head of School, Central Clinical School, following an international search.
Adverse effects of antiseizure drugs little changed over 30 years
![]() |
| Dr Zhibin (Ben) Chen |
An international study led by Monash University scientists has shown that tolerability to antiseizure medication (ASM) has not improved over 30 years. This was despite the advent of nearly 20 ‘second-generation’ drugs – those developed after 1980 – designed to better the earlier treatments.
Tolerability is a key determinant of the effectiveness of epilepsy treatment; greater effort to improve it was needed in ASM development, the paper urges.
Toxic effects of anti-epileptic drugs 'overstated'
Dr Emma Foster is a neurologist and
PhD student working on epilepsy
|
Anti-epileptic drugs (AEDs) have frequently been linked to cognitive impairment such as difficulties in concentrating, learning, understanding and remembering, which can be more disabling to the patients taking them than the seizures for which they are prescribed.\
But studies looking into this in the past haven’t always taken into account other factors affecting the patient that may also affect cognition such as advanced age, increased frequency of seizures and mood disorders such as depression, said Central Clinical School (CCS) PhD student Emma Foster.
Subscribe to:
Posts (Atom)



